NCT06287606

A Phase 3 Clinical Trials for Bowel Preparation for Colonoscopy

A Prospective, Randomized, Investigator-blinded, Parallel, Multi-center, Phase 3 Trial in Bowel Preparation for Colonoscopy

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 161 (actual)
• Sponsor: Taejoon Pharmaceutical Co., Ltd. · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Accepted

Summary

A prospective randomized study compared to the active control. Researchers compare colon cleansing in patients undergoing colonoscopy

Detailed description

This is a prospective randomized study compared with active control arm. The investigators compare the colon cleansing in patients undergoing colonoscopy.

Conditions

• Bowel Preparation

Interventions

Type	Name	Description
DRUG	CTP0302-A	Subjects randomized into group CTP0302-A will take a bowel preparation from the evening until the following morning.
DRUG	CTP0302-B	Subjects randomized into group CTP0302-B will take a bowel preparation on the Colonoscopy day
DRUG	Conventional OST	Subjects randomized into group Conventional OST will take a bowel preparation from the evening until the following morning.

Timeline

• Start date: 2023-08-29
• Primary completion: 2024-01-04
• Completion: 2024-01-04
• First posted: 2024-03-01
• Last updated: 2024-11-29

Locations

1 site across 1 country: South Korea